Form CORRESP - Correspondence:
SEC Accession No. 0001437749-17-001839
Filing Date
2017-02-07
Accepted
2017-02-07 15:32:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 16233
  Complete submission text file 0001437749-17-001839.txt   17417
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 7389 Services-Business Services, NEC